In patients with type II diabetes, cardiovascular disease (CVD) is highly prevalent and a major cause of premature mortality and plasma homocysteine (Hcy) levels are increased by 3-4 folds. Hyperhomocysteinemia (hHcy), elevated plasma concentrations of Hcy, has been established as an independent and significant risk factor for CVD, and has been suggested to be responsible for CVD in diabetes that is not explained by traditional risk factors. However, the role of HHcy in diabetic atherosclerosis has not been studied in experimental model. We have previously proposed that Hcy promotes atherosclerosis by stimulating vascular aortic smooth muscle cell (VSMC) proliferation and by inhibiting endothelial cell (EC) growth, and reported that HHcy accelerated spontaneous atherosclerosis in mice. Recently, we found that Hcy potentiated the diabetic inhibitions on EC growth and eNOS activities in human aortic endothelial cells (HAEC). A PKC inhibitor, GFX, reversed these inhibitions. We hypothesize that Hcy potentiates diabetic endothelium damage and eNOS inactivation via PKC activation, which contributes to high prevalence of atherosclerosis in diabetes. This project will study this hypothesis utilizing three linked specific aims. First, in Aim 1, experiments will evaluate the role and mechanisms of Hcy on endothelial cell growth inhibition in diabetes using in vitro and in vivo models. Second, in Aim 2, studies are proposed to determine the role and mechanism of Hcy in eNOS inactivation and PKC activation. Third, in Aim 3, studies will determine the effect of HHcy on endothelial function and atherosclerosis in animal model of diabetes and atherosclerosis. We believe this project will lead to fundamental new insights into the identification of mechanistic links between Hcy and diabetic atherosclerosis. If we can identify the key events in Hcy-induced atherosclerosis in diabetes, genetic or biochemical approaches to block these steps could lead to new therapeutic approaches ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL082774-01A1
Application #
7151086
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Rabadan-Diehl, Cristina
Project Start
2006-06-01
Project End
2011-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
1
Fiscal Year
2006
Total Cost
$375,000
Indirect Cost
Name
Temple University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Cueto, Ramon; Zhang, Lixiao; Shan, Hui Min et al. (2018) Identification of homocysteine-suppressive mitochondrial ETC complex genes and tissue expression profile - Novel hypothesis establishment. Redox Biol 17:70-88
Cheng, Zhongjian; Shen, Xinggui; Jiang, Xiaohua et al. (2018) Hyperhomocysteinemia potentiates diabetes-impaired EDHF-induced vascular relaxation: Role of insufficient hydrogen sulfide. Redox Biol 16:215-225
Xu, Yanjie; Xia, Jixiang; Liu, Suxuan et al. (2017) Endocytosis and membrane receptor internalization: implication of F-BAR protein Carom. Front Biosci (Landmark Ed) 22:1439-1457
Dai, Jin; Fang, Pu; Saredy, Jason et al. (2017) Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation. J Hematol Oncol 10:141
Yang, Jiyeon; Fang, Pu; Yu, Daohai et al. (2016) Chronic Kidney Disease Induces Inflammatory CD40+ Monocyte Differentiation via Homocysteine Elevation and DNA Hypomethylation. Circ Res 119:1226-1241
Xi, Hang; Zhang, Yuling; Xu, Yanjie et al. (2016) Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells. Circ Res 118:1525-39
Liu, Suxuan; Xiong, Xinyu; Thomas, Sam Varghese et al. (2016) Analysis for Carom complex, signaling and function by database mining. Front Biosci (Landmark Ed) 21:856-72
Nelson, Jun; Wu, Yi; Jiang, Xiaohua et al. (2015) Hyperhomocysteinemia suppresses bone marrow CD34+/VEGF receptor 2+ cells and inhibits progenitor cell mobilization and homing to injured vasculature-a role of ?1-integrin in progenitor cell migration and adhesion. FASEB J 29:3085-99
Cheng, Zhongjian; Jiang, Xiaohua; Pansuria, Meghana et al. (2015) Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via ?-calpain activation. Diabetes 64:947-59
Liu, Suxuan; Xiong, Xinyu; Zhao, Xianxian et al. (2015) F-BAR family proteins, emerging regulators for cell membrane dynamic changes-from structure to human diseases. J Hematol Oncol 8:47

Showing the most recent 10 out of 32 publications